|
1
|
Toussaint E, Bahel-Ball E, Vekemans M,
Georgala A, Al-Hakak L, Paesmasns M and Aoun M: Cause of fever in
cancer patients (prospective study over 477 episodes). Support Care
Cancer. 14:763–769. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nachman JB and Honig GR: Fever and
neutropenia in children with neoplastic disease: An analysis of 158
episodes. Cancer. 45:407–412. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pagano L, Caira M, Rossi G, Tumbarello M,
Fanci R, Garzia MG, Vianelli N, Filardi N, De Fabritiis P, Beltrame
A, et al: A prospective survey of febrile events in hematological
malignancies. Ann Hematol. 91:767–774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park S, Kang CI, Chung DR, Peck KR, Kim WS
and Kim SJ: Clinical significance of non-neutropenic fever in the
management of diffuse large B-cell lymphoma patients treated with
rituximab-CHOP: Comparison with febrile neutropenia and risk factor
analysis. Cancer Res Treat. 47:448–457. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bacci G, Ferrari S, Longhi A, Picci P,
Mercuri M, Alvegard TA, Saeter G, Donati D, Manfrini M, Lari S, et
al: High-dose ifosfamide in combination with high-dose
methotrexate, adriamycin and cysplatin in the neoadjuvant treatment
of extremity osteosarcoma: Preliminary results of an Italian
Sarcoma Group/Scandinavian Sarcoma Group pilot study. J Chemother.
14:198–206. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lewin J, Wieringa S, Collins M, Desai J,
Orme L, Lingaratnam S and Thomas DM: Intra-patient dose escalation
in Ewing's sarcoma treated with vincristine, doxorubicin,
cyclophosphamide alternating with ifosfamide and etoposide: A
retrospective review. Clin Sarcoma Res. 3:152013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schmitt T, Lehner B, Kasper B, Bischof M,
Roeder F, Dietrich S, Dimitrakopoulou-Strauss A, Strauss LG,
Mechtersheimer G, Wuchter P, et al: A phase II study evaluating
neo/adjuvant EIA chemotherapy, surgical resection and radiotherapy
in high-risk soft tissue sarcoma. BMC Cancer. 11:5102011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kalofonos HP, Kourousis C, Karamouzis MV,
Iconomou G, Tsiata E, Tzorzidis F, Megas P, Lambiris E and
Georgoulias V: A phase II study of docetaxel and epirubicin in
advanced adult soft tissue sarcomas (STS). Sarcoma. 8:129–133.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Judson I, Verweij J, Gelderblom H,
Hartmann JT, Schöffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan
J, Hohenberger P, et al: Doxorubicin alone versus intensified
doxorubicin plus ifosfamide for first-line treatment of advanced or
metastatic soft-tissue sarcoma: A randomised controlled phase 3
trial. Lancet Oncol. 15:415–423. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Morii T, Mochizuki K, Tajima T, Ichimura S
and Satomi K: Surgical site infection in malignant soft tissue
tumors. J Orthop Sci. 17:51–57. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakamura T, Matsumine A, Matsubara T,
Asanuma K, Uchida A and Sudo A: Clinical characteristic of patients
with large and deep soft tissue sarcomas. Oncol Lett. 10:841–844.
2015.PubMed/NCBI
|
|
12
|
Nakamura T, Matsumine A, Uchida A, Kawai
A, Nishida Y, Kunisada T, Araki N, Sugiura H, Tomita M, Yokouchi M,
et al: Clinical outcomes of Kyocera Modular Limb Salvage System
after resection of bone sarcoma of distal part of the femur: The
Japanese Musculoskeletal Oncology Group Study. Int Orthop.
38:825–830. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zell JA and Chang JC: Neoplastic fever: A
neglected paraneoplastic syndrome. Support Care Cancer. 13:870–877.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dinarello CA and Bunn PA Jr: Fever. Semin
Oncol. 24:288–298. 1997.PubMed/NCBI
|
|
15
|
Chang JC and Gross HM: Neoplastic fever
responds to the treatment of an adequate dose of naproxen. J Clin
Oncol. 3:552–558. 1985.PubMed/NCBI
|
|
16
|
Johnson M: Neoplastic fever. Palliat Med.
10:217–224. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Browder AA, Huff JW and Petersdorf RG: The
significance of fever in neoplastic disease. Ann Intern Med.
55:932–942. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Osaka S, Fujimoto Y, Yamazaki H, Suzuki K,
Sawada S and Hayashi N: Interleukin-1 alpha producing synovial
sarcoma with prolonged fever: A case report. Jpn J Clin Oncol.
28:436–440. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hamada T, Komiya S, Hiraoka K, Zenmyo M,
Morimatsu M and Inoue A: IL-6 in a pleomorphic type of malignant
fibrous histiocytoma presenting high fever. Hum Pathol. 29:758–761.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Osaka S, Hayakawa S, Yoshida Y, Sakurada
E, Ryu J and Sugitani M: Interleukin-8 producing malignant fibrous
histiocytoma with prolonged fever. Acta Histochem Cytochem.
39:17–21. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Freifeld AG, Bow EJ, Sepkowitz KA, et al:
the Infectious Diseases Society of America: Clinical practice
guideline for the use of antimicrobial agents in neutropenic
patients with cancer: 2010 update by the Infectious Diseases
Society of America. Clin Infect Dis. 52:e56–e93. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kiyosawa T, Higaki H and Nakayama Y:
Liposarcoma associated with fever and reversible hepatic
dysfunction. Int J Dermatol. 36:132–134. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chang JC: Antipyretic effect of naproxen
and corticosteroids on neoplastic fever. J Pain Symptom Manage.
3:141–144. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mantovani G, Maccio A, Pisano M, et al:
Tumor-associated lympho-monocytes from neoplastic effusions are
immunologically defective in comparison with patients autologous
PBMCs are capable of releasing high amounts of various cytokines.
Int J Cancer. 71:724–731. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakanishi H, Yoshikawa K, Joyama S, et al:
Interleukin-6/soluble interleukin-6 receptor signaling attenuated
proliferation and invasion, and induces morphological changes of a
newly established pleomorphic malignant fibrous histiocytoma cell
line. Am J Pathol. 165:471–480. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kathula SK, Shah K, Polenakovik H and
Koduri J: Cyclo-oxygenase II inhibitors in the treatment of
neoplastic fever. Support Care Cancer. 11:258–259. 2003.PubMed/NCBI
|
|
28
|
Tsavaris N, Zinelis A, Karabelis S,
Beldecos D, Bacojanis C, Milonacis N, Karvounis N and Kosmidis P: A
randomized trial of the effect of three non-steroid
anti-inflammatory agents in ameliorating cancer-induced fever. J
Intern Med. 228:451–455. 1990. View Article : Google Scholar : PubMed/NCBI
|
